Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial

CONTEXT: Acetyl-l-carnitine (ALC), a mitochondrial carrier involved in lipid oxidation and glucose metabolism, decreased systolic blood pressure (SBP), and ameliorated insulin sensitivity in hypertensive nondiabetic subjects at high cardiovascular risk. OBJECTIVE: To assess the effects of ALC on SBP...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvanova, Aneliya, Trillini, Matias, Podestà, Manuel A, Iliev, Ilian P, Aparicio, Carolina, Perna, Annalisa, Peraro, Francesco, Rubis, Nadia, Gaspari, Flavio, Cannata, Antonio, Ferrari, Silvia, Bossi, Antonio C, Trevisan, Roberto, Parameswaran, Sreejith, Chávez-Iñiguez, Jonathan S, Masnic, Fahrudin, Seck, Sidy Mohamed, Jiamjariyaporn, Teerayuth, Cortinovis, Monica, Perico, Luca, Sharma, Kanishka, Remuzzi, Giuseppe, Ruggenenti, Piero, Warnock, David G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2018
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912091/
https://www.ncbi.nlm.nih.gov/pubmed/29696241
http://dx.doi.org/10.1210/js.2017-00426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912091/
https://www.ncbi.nlm.nih.gov/pubmed/29696241
http://dx.doi.org/10.1210/js.2017-00426

Ejemplares similares